EMIS Group PLC Trading Statement (2010C)
January 18 2018 - 1:01AM
UK Regulatory
TIDMEMIS
RNS Number : 2010C
EMIS Group PLC
18 January 2018
18 January 2018
EMIS Group plc
("EMIS Group" or "the Group")
Trading update
Notice of final results
EMIS Group plc (AIM: EMIS.L), the UK leader in connected
healthcare software and services, today announces a trading update
for the year ended 31 December 2017.
Overview
Trading for the year has been in line with the Board's
expectations (excluding the impact of the service level reporting
issues separately announced this morning). Full year revenue was
slightly ahead of the comparative period as the Group continued to
benefit from growing recurring revenue, strong market shares and
good momentum in its order books and pipelines. The previously
announced internal reorganisation programme has been completed,
focusing on improving day to day operational management.
Divisional review
In Primary, Community & Acute Care, the Group's leading
primary care market share has been maintained. In Northern Ireland,
implementation of EMIS Web for primary care is progressing well,
with approximately half of the estate now live. In Scotland the
process for the procurement of EMIS Web is continuing and the Group
expects an update shortly regarding progress in the Welsh
re-procurement. Community market share grew with further contract
wins in the period. Acute care delivered growth in the second half
but the hospital market overall remained subdued.
As well as maintaining a leading market share in Community
Pharmacy, the roll out of ProScript Connect, the Group's next
generation pharmacy dispensary management product, has continued,
driving a strong performance.
Specialist & Care delivered revenue growth and a return to
profit in the second half of the year as the turnaround plan
continues to be executed.
In Patient, the websites and mobile applications for both
Patient.info and Patient Access have been refreshed as part of the
plan to deliver an evolving online digital platform.
Financial position
The Group has a strong balance sheet with net cash of GBP14.0m
as at 31 December 2017 (31 December 2016: net debt of GBP0.4m).
The Group will provide an update on current trading at the time
of its full year results along with an update on the issues
announced separately this morning relating to EMIS Web and the
future impact on the Group.
Notice of final results
The Group intends to announce its results for the year ended 31
December 2017 on 14 March 2018.
For further information, contact:
EMIS Group plc Tel: 0113 380 3000
Andy Thorburn, CEO
Peter Southby, CFO
www.emisgroupplc.com
Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000
Oliver Hardy/Simon Willis/James Black
MHP Communications Tel: 020 3128 8788
Reg Hoare/Giles Robinson/Charlie Barker
emis@mhpc.com
Notes to Editors
EMIS Group is the UK leader in connected healthcare software and
services. Its solutions are widely used across every major UK
healthcare setting from primary, community & acute care, to
high street pharmacies and specialist care services. EMIS Group
helps healthcare professionals in over 10,000 organisations share
vital information, facilitating better, more efficient healthcare
and supporting longer and healthier lives.
EMIS Group serves the following healthcare markets under the
EMIS Health brand:
-- Primary, Community & Acute Care, as the UK leader in
clinical management systems for healthcare providers and
commissioners. EMIS Health products, including the flagship EMIS
Web, hold over 40 million patient records and are used by more than
100,000 professionals in nearly 6,000 healthcare organisations.
-- Community Pharmacy, with the UK's single most used integrated
community pharmacy and retail system.
-- Specialist Care, as England's leading provider of diabetic eye screening software and other ophthalmology-related solutions.
These markets are also supported by other EMIS Group
businesses:
-- under the Patient brand, the UK's leading independent
provider of patient-centric medical and well-being information and
related transactional services.
-- under the Egton brand, providing specialist ICT
infrastructure, hardware and engineering services, and non-clinical
software into health and social care.
-- under the EMIS Care brand, providing healthcare screening
programmes such as diabetic eye screening.
LEI: 213800K474ZZK76NX913
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTUBVARWSAAAUR
(END) Dow Jones Newswires
January 18, 2018 02:01 ET (07:01 GMT)
Emis (LSE:EMIS)
Historical Stock Chart
From Apr 2024 to May 2024
Emis (LSE:EMIS)
Historical Stock Chart
From May 2023 to May 2024